Medtronic (MDT) to acquire Scientia Vascular for USD 550mln with the acquisition expected to close in H1 '27; acquisition expected to be minimally dilutive to Medtronic adj. EPS in FY27

Medtronic's acquisition of Scientia Vascular for USD 550 million is strategically aimed at strengthening its portfolio in the health care equipment sector. With expectations that the deal will be minimally dilutive to adjusted EPS in FY27, this move signals confidence in growth potential and could enhance Medtronic's competitive position. Traders should monitor how this acquisition might influence market sentiment and stock performance, particularly in the health care sector.